Indeed, our analyses confirmed that the estimated EpCAMhigh cell fraction (P3/P2) does not correlate with clinical parameters, apart from age, and does not seem to add specificity to the PSMA labeling (P2 fraction) in PCa detection. This evidence concerns the gene FOLH1 and posterior cortical atrophy.